Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
Journal of Experimental & Clinical Cancer Research : CR|March 7, 2025
Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancerFlorian Janke, Mateo Gasser, Arlou K Angeles, et al.
Genes, Chromosomes & Cancer|February 28, 2023
Real-world data for precision cancer medicine-A European perspectivePetros Christopoulos, Richard Schlenk, Daniel Kazdal, et al.
Clinical and Translational Radiation Oncology|August 11, 2023
Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapyChristoph A Fink, Fabian Weykamp, Sebastian Adeberg, et al.
Translational Lung Cancer Research|June 24, 2021
Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsiesPetros Christopoulos, Steffen Dietz, Arlou K Angeles, et al.
British Journal of Cancer|June 12, 2024
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinomaJan Budczies, Eva Romanovsky, Martina Kirchner, et al.
Cold Spring Harbor Molecular Case Studies|January 21, 2022
Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case reportMarkus Ball, Petros Christopoulos, Martina Kirchner, et al.
Frontiers in Oncology|October 7, 2022
Real-world efficacy and safety of mobocertinib in <i>EGFR</i> exon 20 insertion-mutated lung cancerWaleed Kian, Petros Christopoulos, Areen A Remilah, et al.
BMC Cancer|May 2, 2021
Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samplesKatharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, et al.
Annals of the Rheumatic Diseases|April 1, 2024
Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic diseaseKarolina Gente, Manuel Feisst, Dorothea Marx, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2023
Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutationsPetros Christopoulos, Thibaud Prawitz, Jin-Liern Hong, et al.
Pageof 18